Morgan Stanley’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $583K | Sell |
|
|||||
|
2023
Q4 | $2.94M | Buy |
|
|||||
|
2023
Q3 | $1.15M | Buy |
|
|||||
|
2023
Q2 | $1.02M | Buy |
|
|||||
|
2023
Q1 | $666K | Buy |
|
|||||
|
2022
Q4 | $105K | Buy |
|
|||||
|
2022
Q3 | $25K | Sell |
|
|||||
|
2022
Q2 | $43K | Buy |
|
|||||
|
2022
Q1 | $39K | Buy |
|
|||||
|
2021
Q4 | $19K | Sell |
|
|||||
|
2021
Q3 | $28K | Sell |
|
|||||
|
2021
Q2 | $72K | Buy |
|
|||||
|
2021
Q1 | $38K | Buy |
|
|||||
|
2020
Q4 | $34K | Buy |
|
|||||
|
2020
Q3 | $15K | Buy |
|
|||||
|
2020
Q2 | $12K | Sell |
|
|||||
|
2020
Q1 | $17K | Sell |
|
|||||
|
2019
Q4 | $34K | Sell |
|
|||||
|
2019
Q3 | $146K | Buy |
|
|||||
|
2019
Q2 | $41K | Sell |
|
|||||
|
2019
Q1 | $55K | Buy |
|
|||||
|
2018
Q4 | $30K | Sell |
|
|||||
|
2018
Q3 | $86K | Sell |
|
|||||
|
2018
Q2 | $321K | Buy |
|
|||||
|
2018
Q1 | $307K | Buy |
|
|||||
|
2017
Q4 | $352K | Buy |
|
|||||
|
2017
Q3 | $393K | Sell |
|
|||||
|
2017
Q2 | $758K | Buy |
|
|||||
|
2017
Q1 | $925K | Sell |
|
|||||
|
2016
Q4 | $2.79M | Sell |
|
|||||
|
2016
Q3 | $5.69M | Buy |
|
|||||
|
2016
Q2 | $4.76M | Buy |
|
|||||
|
2016
Q1 | $7.33M | Sell |
|
|||||
|
2015
Q4 | $8.04M | Buy |
|
|||||
|
2015
Q3 | $8.23M | Buy |
|
|||||
|
2015
Q2 | $10.1M | Buy |
|
|||||
|
2015
Q1 | $9.38M | Sell |
|
|||||
|
2014
Q4 | $9.17M | Buy |
|
|||||
|
2014
Q3 | $6.53M | Buy |
|
|||||
|
2014
Q2 | $3.67M | Sell |
|
|||||
|
2014
Q1 | $4.24M | Sell |
|
|||||
|
2013
Q4 | $5.28M | Buy |
|
|||||
|
2013
Q3 | $202K | Sell |
|
|||||
|
2013
Q2 | $403K | Buy |
|